Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Evaluation of the Performance and Safety of Hyalo Gyn® Gel Compared to Placebo in Postmenopausal Breast Cancer Survivors [NA]

View source ↗

Summary

A clinical trial update assessing the performance and safety of Hyalo Gyn Gel versus placebo for vulvo-vaginal atrophy in postmenopausal breast cancer survivors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyalo Gyn Gel (hyaluronic acid gel)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Vulvo Vaginal Atrophy | NA | Status: ACTIVE_NOT_RECRUITING